Risk of Metabolic Syndrome and Fatty Liver Diseases in Gastric Cancer Survivors: A Propensity Score-Matched Analysis.
Sang Jo HanSu Jung BaikYoung Hoon YoonJie Hyun KimHye Sun LeeSoyoung JeonHyojin ParkPublished in: The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi (2023)
OpGC showed lower risks of metabolic syndrome, fatty liver by ultrasonography, and MAFLD than non-cancer subjects, but there were no significant differences in the risks between non-OpGC and non-cancer subjects. Further studies on metabolic syndrome and fatty liver diseases in gastric cancer survivors are warranted.